Clinical Efficacy of Crizotinib in Advanced ALK Positive Non-small Cell Lung Cancer
Background and objective The aim of this study is to explore clinical efficacy of crizotinib in advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer. Methods Twenty-eight patients with advanced non-small cell lung cancer habouring ALK positive were randomly divided into criz...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Chinês |
| Argitaratua: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-10-01
|
| Saila: | Chinese Journal of Lung Cancer |
| Gaiak: | |
| Sarrera elektronikoa: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|